Search results
Prothena (PRTA) Soars 18.7%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 6 months agoProthena (PRTA) witnessed a jump in share price last session on above-average trading volume. The...
Prothena (NASDAQ:PRTA) delivers shareholders strong 57% CAGR over 3 years, surging 6.6% in the last...
Simply Wall St. via Yahoo Finance· 2 years agoIt might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its...
Prothena (PRTA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 6 months agoProthena (PRTA) possesses the right combination of the two key ingredients for a likely earnings...
Prothena Corporation plc (NASDAQ:PRTA) Shares Could Be 36% Below Their Intrinsic Value Estimate
Simply Wall St. via Yahoo Finance· 9 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Prothena fair value estimate is US$109...
Prothena (NASDAQ:PRTA) shareholder returns have been strong, earning 207% in 5 years
Simply Wall St. via Yahoo Finance· 5 months agoThe last three months have been tough on Prothena Corporation plc (NASDAQ:PRTA) shareholders, who...
Prothena Corporation plc's (NASDAQ:PRTA) Fundamentals Look Pretty Strong: Could The Market Be Wrong...
Simply Wall St. via Yahoo Finance· 2 years agoWith its stock down 30% over the past three months, it is easy to disregard Prothena (NASDAQ:PRTA)....
Pinning Down Prothena Corporation plc's (NASDAQ:PRTA) P/S Is Difficult Right Now
Simply Wall St. via Yahoo Finance· 7 months agoYou may think that with a price-to-sales (or "P/S") ratio of 48.7x Prothena Corporation plc...
Prothena Corporation plc (NASDAQ:PRTA) Analysts Just Trimmed Their Revenue Forecasts By 29%
Simply Wall St. via Yahoo Finance· 12 months agoOne thing we could say about the analysts on Prothena Corporation plc (NASDAQ:PRTA) - they aren't...
Why RBC Capital Sees 'Multiple High-Risk' On This Neurology-Focused Stock
Benzinga via Yahoo Finance· 2 years agoRBC Capital Markets writes that Prothena Corporation plc (NASDAQ: PRTA) believes that the recent...
Prothena (PRTA) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoProthena (PRTA) delivered earnings and revenue surprises of -72.55% and 93.48%, respectively, for...